Review
Published on 03 Aug 2023
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1140463
- 21,792 views
- 59 citations
71 articles related to "Immunotharapy"
Articles
Review
Published on 19 Apr 2023
Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1176724
- 12,838 views
- 39 citations
Case Report
Published on 06 Aug 2021
Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations—A Report of a Stunning Success in a 37-Year-Old Patient
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.684733
- 4,640 views
- 12 citations
Mini Review
Published on 25 Mar 2022
Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review
in Nutritional Immunology
Frontiers in Nutrition
doi 10.3389/fnut.2022.810472
- 4,678 views
- 7 citations
Editorial
Published on 20 Jun 2023
Editorial: Ionizing radiation reprograms tumor immune microenvironment by inducing immunogenic cell death
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1235024
- 3,236 views
Clinical Trial
Published on 31 Jul 2023
Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2023.1189752
- 11,520 views
- 65 citations
Editorial
Published on 09 Nov 2023
Editorial: Novel diagnostic and therapeutic strategies in the management of cerebral gliomas, Volume II
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1306332
- 1,430 views
Review
Published on 19 Feb 2024
Insights into the heterogeneity of iNKT cells: tissue-resident and circulating subsets shaped by local microenvironmental cues
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1349184
- 7,665 views
- 18 citations
Review
Published on 25 Aug 2022
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.953410
- 16,721 views
- 53 citations
Review
Published on 25 May 2021
CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2021.662064
- 52,726 views
- 141 citations
Review
Published on 16 Mar 2021
Modeling Radioimmune Response—Current Status and Perspectives
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.647272
- 4,242 views
- 16 citations
Original Research
Published on 16 May 2022
Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2022.811567
- 5,963 views
- 9 citations
Original Research
Published on 20 May 2021
An Eight-Gene Hypoxia Signature Predicts Survival in Pancreatic Cancer and Is Associated With an Immunosuppressed Tumor Microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.680435
- 11,120 views
- 42 citations
Original Research
Published on 01 Apr 2022
A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer
in Cancer Genetics and Oncogenomics
Frontiers in Genetics
doi 10.3389/fgene.2022.834731
- 5,832 views
- 27 citations
Original Research
Published on 26 Apr 2022
Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
in Cancer Cell Biology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2022.835043
- 4,807 views
- 9 citations
Editorial
Published on 10 Nov 2022
Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1075329
- 3,197 views
- 3 citations